Iterum Therapeutics plc (ITRMF) Current Assets (2017 - 2025)

Iterum Therapeutics has reported Current Assets for 9 years, with the latest figure at $13.7 million in Q3 2025.

• On a quarterly basis, Current Assets fell 13.42% year-over-year to $13.7 million in Q3 2025; TTM through Sep 2025 was $13.7 million, a 13.42% decrease from a year earlier, with the FY2024 full-year figure at $24.8 million, down 3.16% from the prior year.
• Current Assets was $13.7 million for Q3 2025 at Iterum Therapeutics, down from $14.9 million in the prior quarter.
• The five-year high for Current Assets was $104.2 million in Q1 2021, with the low at $13.5 million in Q1 2025.
• Average Current Assets over 5 years is $49.1 million, with a median of $47.7 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2024: Current Assets jumped 648.1% in 2021, then sank 71.26% in 2024.
• Over 5 years, Current Assets stood at $83.3 million in 2021, then fell by 25.01% to $62.4 million in 2022, then plunged by 59.01% to $25.6 million in 2023, then declined by 3.16% to $24.8 million in 2024, then sank by 44.62% to $13.7 million in 2025.
• The last three Current Assets figures came in at $13.7 million (Q3 2025), $14.9 million (Q2 2025), and $13.5 million (Q1 2025), per Business Quant data.